New hires and promotions in the biopharma industry, including: Biond, Celyad, Iteos, Neoleukin, Oxford Biomedica, Samumed, Sanifit, Swanbio, Trisalus.
New and updated preclinical and clinical data presented by biopharma firms at the American Society of Clinical Oncology’s annual meeting May 29-31, including: Ascentage, Celyad, Engeneic, Faron Immutep, Innovent, Kazia, Nanobiotix, Nkmax, Taiho, Treos.
Biopharmas raising money in public or private financings, including: Adaptimmune, Allogene, Baudax Bio, Biolinerx, Calliditas, Cleveland Biolabs, Nabriva.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aileron, Antibe, Belx, Biomarin, CTI, Gilead, GSK, Histogen, Iterum, Lineage Cell, Merck, Mesoblast, Moderna, Novartis, Novus, Ocugen, Pfizer, TLC.
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbvie, Acacia, Alligator, Anixa, Axim, Biotheus, Cellectar, Censa, Codiak, Cosmo, Diffusion, Emergent, G3, Hua, Intellia, Jacobio, Junshi, Juvenescence, Kalytera, Mateon, Merck, Mimivax, Motif, Ontochem, Oryzon, Proteostasis, PTC, Rakuten Medical, Regeneron, Resverlogix, Revance, Sanofi, Synlogic, Tonix, Fujifilm Diosynth, Twist Bioscience, Proteona, Spark, Vault.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbvie, Accord, Altimmune, ANI, Astrazeneca, Aveo, Compugen, Cytodyn, Eli Lilly, Genentech, Henlius, Hutchison China (Chi-Med), J&J, Longeveron, Merck, Mundipharma, Myovant, Myr, Opko.
The latest global regulatory news, changes and updates affecting biopharma, including: Apotex.